Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant level (Expand Search)
linear decrease » linear increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant level (Expand Search)
linear decrease » linear increase (Expand Search)
-
1821
-
1822
GWAS analysis using Cluster 2 data (shown in S1 Fig).
Published 2024“…The dashed line indicates the permuted threshold for genome-wide significance <b><i>p</i></b> = <b>3.68</b>×<b>10</b><sup><b>−5</b></sup>(0.05/1357 SNPs). …”
-
1823
GWAS analysis using Cluster 3 data (shown in S1 Fig).
Published 2024“…The dashed line indicates the permuted threshold for genome-wide significance <b><i>p</i></b> = 2<b>.80</b>×<b>10</b><sup><b>−5</b></sup>(0.05/1784 SNPs). …”
-
1824
GWAS analysis using only Cluster 1 data (shown in S1 Fig).
Published 2024“…The dashed line indicates the permuted threshold for genome-wide significance <b><i>p</i></b> = <b>4.03</b>×<b>10</b><sup><b>−5</b></sup> (0.05/1242 SNPs). …”
-
1825
GWAS analysis using Cluster 4 data (shown in S1 Fig).
Published 2024“…The dashed line indicates the permuted threshold for genome-wide significance <b><i>p</i></b> = <b>7.91</b>×<b>10</b><sup><b>−6</b></sup> (0.05/6314 SNPs). …”
-
1826
GWAS analysis identifies several single nucleotide polymorphisms (SNPs) that are associated with the changes in viral copies.
Published 2024“…The dashed line indicates the permuted threshold for genome-wide significance <b><i>p</i></b> = <b>4.67</b>×<b>10</b><sup><b>−6</b></sup> (0.05/10697 SNPs). …”
-
1827
-
1828
GWAS analysis identifies several single nucleotide polymorphisms (SNPs) that are associated with the changes in viral copies.
Published 2024“…The dashed line indicates the permuted threshold for genome-wide significance <b><i>p</i></b> = <b>4.67</b>×<b>10</b><sup><b>−6</b></sup>. …”
-
1829
Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. Monocytes and NK cells purified from PBMC collected from 10 RZV recipients (demographics in S4 Table) before vaccination (D0) and 90 days post-vaccination (D90) were combined ex vivo and stimulated with VZV-rgE. A subset of D0 monocyte & NK cocultures was also treated with the TGFβ1 inhibitor LY (D0 LY), and a subset of D90 cocultures were supplemented with rhTGFβ1. The graph shows individual data points, means and p values calculated by Friedman test for repeated measures with FDR correction. LY treatment of cells collected on D0 significantly increased their activation to levels similar to D90. Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.
Published 2025“…Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.…”
-
1830
-
1831
-
1832
-
1833
-
1834
-
1835
-
1836
-
1837
-
1838
-
1839
-
1840